An Analysis Based on Molecular Docking and Molecular Dynamics Simulation Study of Bromelain as Anti-SARS-CoV-2 Variants

The rapid spread of a novel coronavirus known as SARS-CoV-2 has compelled the entire world to seek ways to weaken this virus, prevent its spread and also eliminate it. However, no drug has been approved to treat COVID-19. Furthermore, the receptor-binding domain (RBD) on this viral spike protein, as...

Descripción completa

Detalles Bibliográficos
Autores principales: Tallei, Trina Ekawati, Fatimawali, Yelnetty, Afriza, Idroes, Rinaldi, Kusumawaty, Diah, Emran, Talha Bin, Yesiloglu, Talha Zahid, Sippl, Wolfgang, Mahmud, Shafi, Alqahtani, Taha, Alqahtani, Ali M., Asiri, Saeed, Rahmatullah, Mohammed, Jahan, Rownak, Khan, Md. Arif, Celik, Ismail
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8417730/
https://www.ncbi.nlm.nih.gov/pubmed/34489706
http://dx.doi.org/10.3389/fphar.2021.717757

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8417730/
https://www.ncbi.nlm.nih.gov/pubmed/34489706
http://dx.doi.org/10.3389/fphar.2021.717757

Ejemplares similares